| P2093 | author name string | M Zhang | |
| | S H Brown | |
| | J Q Feng | |
| | C Anaclet | |
| | R Parmentier | |
| | J S Lin | |
| | A D Medhurst | |
| | N Upton | |
| | P Franco | |
| | J C Roberts | |
| | R X Guo | |
| | C Buda | |
| | G Guidon | |
| | J P Sastre | |
| P2860 | cites work | EFNS guidelines on management of narcolepsy. | Q36598957 |
| | Narcolepsy and the hypocretin system--where motion meets emotion | Q36600966 |
| | Narcolepsy with cataplexy | Q36733271 |
| | Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine | Q37597558 |
| | Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. | Q41201301 |
| | Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats | Q42581834 |
| | Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice | Q43130890 |
| | Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs | Q43780972 |
| | Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. | Q44567477 |
| | [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution | Q44691364 |
| | Potential interest in powerful and specific ligands for the histamine H3 receptor | Q46411626 |
| | Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121. | Q48520085 |
| | Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness | Q48612161 |
| | Slow wave sleep-inducing effects of first generation H1-antagonists | Q48739208 |
| | Sedative effects of antihistamines | Q48983829 |
| | Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. | Q49116076 |
| | [Long-term recording of cerebral, muscular and ocular electric activities in mice] | Q68636649 |
| | [Genetic factors as determinants of the waking-sleep cycle in the mouse (author's transl)] | Q68682181 |
| | Sleep and waking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats | Q71512241 |
| | The distribution of histamine H1-receptors in the rat brain: An autoradiographic study | Q72464983 |
| | Changes in histamine H3 receptor responsiveness in mouse brain | Q73315928 |
| | The histamine H3 receptor: an attractive target for the treatment of cognitive disorders | Q24654788 |
| | Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist | Q24671207 |
| | Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control | Q28219144 |
| | Modulation of neurotransmitter release via histamine H3 heteroreceptors | Q28244199 |
| | Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists | Q28270462 |
| | The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders | Q28287403 |
| | Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist | Q28288221 |
| | The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders | Q28292033 |
| | GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models | Q28574369 |
| | Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation | Q29615680 |
| | The physiology of brain histamine. | Q31875011 |
| | Behavioral characterization of mice lacking histamine H(3) receptors. | Q34140174 |
| | Tolerance to daytime sedative effects of H1 antihistamines | Q34152137 |
| | Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 |
| | Keynote review: histamine H3 receptor antagonists reach out for the clinic | Q34479438 |
| | BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology | Q34569432 |
| | Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. | Q34571598 |
| | Histamine H3 receptor antagonists: from target identification to drug leads | Q34585004 |
| | Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons | Q34599381 |
| | Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain | Q34731433 |
| | An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients | Q34754308 |
| | Narcolepsy: genetic predisposition and neuropharmacological mechanisms. REVIEW ARTICLE. | Q35046857 |
| | The role of histamine and the tuberomamillary nucleus in the nervous system | Q35058506 |
| | Genetic and pharmacological aspects of histamine H3 receptor heterogeneity | Q35556324 |
| | ??? | Q28299003 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | narcolepsy | Q189561 |
| P304 | page(s) | 104-117 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice | |
| P478 | volume | 157 | |